Clinical utility of neurofilament light chain as a biomarker for disease onset and progression in hereditary transthyretin amyloidosis

BackgroundNeurofilament light chain levels (NfL) have emerged as a biomarker for early diagnosis and follow-up of hereditary transthyretin variant amyloidosis (ATTRv). We evaluated the most accurate technique for NfL quantifying in ATTRv healthy carriers and symptomatic patients in real-life practic...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Álvaro Gragera-Martínez, Cristina Borrachero Garro, Francisco Muñoz Beamud, Ana Manovel Sánchez, Andrés González Macías, Mariano Pizarro Sánchez, Amelia Jiménez Heffernan, Ana Serrano Mira, Beatriz Macías Dominguez, Sandra Garcia Garrido
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Frontiers Media S.A. 2025-10-01
coleção:	Frontiers in Neurology
Assuntos:	neurofilament ELISA SiMoA transthyretin amyloidosis ATTRv
Acesso em linha:	https://www.frontiersin.org/articles/10.3389/fneur.2025.1660344/full
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!